Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 12/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.46 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9902006 | 0.86 | SCD (0.55) | SCDCYP3A4CYP2D6 | |
| SCHEMBL5541389 | 0.86 | SCD (0.52) | SCDCYP3A4CYP2D6EPHX2KDM4E | |
| SCHEMBL5541289 | 0.84 | SCD (0.50) | SCDCYP3A4CYP2D6EPHX2KDM4E | |
| SCHEMBL5540517 | 0.83 | SCD (0.54) | SCDCYP3A4CYP2D6EPHX2 | |
| SCHEMBL5541771 | 0.83 | SCD (0.49) | SCDCYP3A4CYP2D6EPHX2KDM4E | |
| SCHEMBL5543355 | 0.82 | SCD (0.48) | SCDCYP3A4CYP2D6EPHX2KDM4E | |
| SCHEMBL5542451 | 0.81 | KDM4E (0.64) | SCDCYP3A4CYP2D6EPHX2KDM4E | |
| SCHEMBL5542445 | 0.79 | SCD (0.57) | SCDCYP3A4CYP2D6EPHX2 | |
| SCHEMBL6819584 | 0.77 | UTS2R (0.57) | SCDCYP3A4CYP2D6KDM4ELMNA | |
| SCHEMBL12099559 | 0.76 | SCD (0.55) | SCDCYP3A4CYP2D6EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2462121-A1 | DERIVATIVES OF 2H PYRIDAZIN- 3 -ONES, THEIR PREPARATION AND THEIR USE AS SCD-1 INHIBITORS | Pierre Fabre Médicament (FR) | 2012-06-13 | — | — | EP | disclosed |